Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Impact Biomedical Inc. (IBO) vs Metagenomi Therapeutics, Inc. (MGX)

Impact Biomedical Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Impact Biomedical Inc. is the larger, with a market value of $48.3M against $43.4M — 1.1× the size. Metagenomi Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 6.5×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs −689.2%) and the lower return on invested capital (−22.8% vs 0.00%). Across the 15 metrics below, Metagenomi Therapeutics, Inc. leads on 8 and Impact Biomedical Inc. on 7.

Valuation

Metric IBO MGX Biotechnology median
P/E 6.45 n/m 7.88
P/S 17,528.61 3.19 11.47
P/B 43.78 0.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.49 0.74
EV/Sales 17,756.07 (3.47) 10.73
Earnings yield 15.50% (216.52%) (28.84%)
Free cash flow yield (0.09%) (198.11%) (23.03%)

Profitability

Metric IBO MGX Biotechnology median
Gross margin (1,111.43%) 100.00% 65.16%
Operating margin (14,600.00%) (741.58%) 0.00%
Net margin 2,254.29% (689.20%) 0.00%
Free cash flow margin (1,451.43%) (632.67%) 0.00%
Return on equity 24.01% (60.61%) (57.72%)
Return on assets 4.41% (41.91%) (49.22%)
Return on invested capital (22.81%) 0.00% 0.00%

Growth

Metric IBO MGX Biotechnology median
Revenue growth (TTM) — (59.84%) 5.64%
EPS growth (last fiscal year) 83.48% 0.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric IBO MGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.16 4.50 4.73
Net debt to EBITDA 0.00 1.71 0.96

Dividend

Metric IBO MGX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric IBO MGX Biotechnology median
Market cap 48.27m 43.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack